Intas completed the acquisition of Udenyca—a biosimilar that references Amgen’s febrile neutropenia drug Neulasta—last week ... off-label use of Merck & Co.’s Keytruda in the target ...

Merck’s Keytruda, with more than 40 approved indications, hasn’t yet been able to crack specifically into ovarian cancer. But with promising early results from a phase 3 study in certain ...

Merck KGaA (Merck) has moved to strengthen its position in oncology and rare diseases with a $3.9bn agreement to acquire SpringWorks Therapeutics. Under the deal, Merck will pay $47 per share in ...

Caroline Litchfield; Chief Financial Officer, Executive Vice President; Merck & Co Inc Dean Li; Executive Vice President, President - Merck Research Laboratories; Merck & Co Inc Thank you for ...

FDA approved Merck's Welireg as the first oral therapy for advanced pheochromocytoma or paraganglioma (PPGL). In the LITESPARK-015 trial, Welireg showed a 26% ORR and a 20.4-month median duration ...

First it was Panasonic—now, another major company is planting deeper roots in De Soto. Merck Animal Health has announced an expansion of its De Soto operations, and it’s bringing hundreds of ...

Merck & Co. said it expects to lose $200 million to already-announced tariffs in 2025 amid a roiling trade war between the US and China. The estimate doesn’t account for the possibility that ...

Pharmaceutical company Merck (NYSE:MRK) is set to announce its first quarter earnings result on Thursday, April 24th, before the opening bell. Analysts on consensus expect the company to report ...

She regularly appears on CBS News 24/7 to discuss her reporting. Merck is investing $1 billion to build a U.S. plant in Delaware, in a show of its commitment to domestic manufacturing. The move ...

May 14 (Reuters) - The U.S. Food and Drug Administration said on Wednesday it has approved the expanded use of Merck's (MRK.N), opens new tab cancer drug to treat two rare types of adrenal gland ...

Drugmaker Merck said Tuesday it is investing $1 billion in a new Delaware plant to expand domestic production as it prepares to deal with President Trump’s tariffs. The new facility will produce ...

Thousands of jobs could be on the horizon for American workers as drug manufacturer Merck takes steps to move manufacturing into the U.S., particularly in the form of a $1 billion state-of-the-art ...